Evidence map›Paper›PMID 28017184›Full record

ArticleJournal of substance abuse treatment2017

Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement.

Scott P Stumbo, Bobbi Jo H Yarborough, Dennis McCarty, Constance Weisner, Carla A Green

3 registry-linked trialsAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04491175 nacompletednot on this mapstarted 2022, after this paper: background citation

Addressing Opioid Use Disorder With an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing Pain Relief in Acute and Chronic Low Back Pain

TypeinterventionalSponsorMMJ Labs LLCRan2022 to 2025Enrolled160ConditionsOpioid Use, Low Back PainArmsM-Stim, TENS
NCT04494698 nacompletednot on this mapstarted 2022, after this paper: background citation

Addressing Pain and Disability From Low Back Pain With an External Multimodal Neuromodulation Device

TypeinterventionalSponsorMMJ Labs LLCRan2022 to 2025Enrolled160ConditionsAcute Low-back Pain, Chronic Low-back Pain, Pain, IntractableArmsDuotherm VibraCool Back Device, TENS 8-channel unit
NCT04494841 nacompletednot on this mapstarted 2020, after this paper: background citation

Addressing Feasibility of the DuoTherm in Acute and Chronic Low Back Pain

TypeinterventionalSponsorMMJ Labs LLCRan2020 to 2021Enrolled20ConditionsLow Back Pain, Low Back Sprain, Low Back Pain, RecurrentArmsDuotherm VibraCool Back Device
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Development and Validation of the Decisions to use Opioids Measure.Pain management nursing : official journal of the American Society of Pain Management Nurses · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Scott P StumboKaiser Permanente Northwest Center for Health Research, 3800 N. Interstate Ave, Portland, OR 97227, USA. Electronic address: scott.p.stumbo@kpchr.org.
Bobbi Jo H YarboroughKaiser Permanente Northwest Center for Health Research, 3800 N. Interstate Ave, Portland, OR 97227, USA. Electronic address: bobbijo.h.yarborough@kpchr.org.
Dennis McCartyOHSU/PSU School of Public Health, Oregon Health & Science University, 3181 S.W. Sam Jackson Hill Road, CB 669, Portland, OR 97239, USA. Electronic address: mccartyd@ohsu.edu.
Constance WeisnerDivision of Research, Kaiser Permanente Northern California, 2000 Broadway Ave., Oakland, CA 94612, USA; Department of Psychiatry, University of California, San Francisco, 401 Parnassus, Box 0984, San Francisco, 94143, USA. Electronic address: constance.weisner@kp.org.
Carla A GreenKaiser Permanente Northwest Center for Health Research, 3800 N. Interstate Ave, Portland, OR 97227, USA. Electronic address: carla.a.green@kpchr.org.
Kaiser Permanente Center for Health Research · USKaiser Permanente · USOregon Health & Science University · US

Funding

Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Integrating Addiction Treatment and Medical Care in a Commercial Health PlanR01DA029716 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCCARTY, DENNIS · 2011 to 2015
$3.3M
Adoption of Buprenorphine in an HMO SettingR01DA016341 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCCARTY, DENNIS · 2005 to 2009
$2.9M
NIDA NIH HHS R01 DA016341NIDA NIH HHS R01 DA029716NIDA NIH HHS UG1 DA015815
6 · The paper itself

Abstract

backgroundRisk factors associated with developing opioid use disorders (OUD) are documented, but less is known about different pathways to initiation of opioids or opioid dependence, or how such pathways affect treatment engagement.

methodsWe recruited 283 adults with electronic medical record (EMR) evidence of opioid dependence diagnoses. Open-ended and structured interview items focused on prior opioid treatment experiences, barriers to and knowledge of treatment options. Interviews were audio-recorded, transcribed, and coded. In exploratory analyses, we used a modified grounded theory approach to organize emergent, patient-reported themes describing participants' perceived pathways to opioid dependence.

results121 participants described one or more pathways to OUD. Qualitative analyses revealed five pathway themes. Three pathways were related to pain control: inadequately controlled chronic pain, exposure to opioids during acute pain episodes, and chronic pain among individuals with prior substance use disorders. A fourth pathway included individuals for whom opioids provided relief from emotional distress; the fifth related to recreational or non-medically supervised opioid use. We identified pain-related barriers to reducing/stopping opioids and treatment engagement barriers among individuals who perceived themselves solely as pain patients.

conclusionPatients' perceptions of inadequately controlled pain, patients' previous substance use disorders, and the relief from emotional distress that some patients feel while using opioids are relevant when making clinical decisions about whether to initiate or sustain opioid therapy, and for how to monitor certain individuals. Among individuals with pain and OUD, treatment barriers include fear of uncontrolled pain, and stigmatization of being treated alongside people with non-medical opioid use.

Indexed as

Acute PainAdultAffective SymptomsChronic PainFemaleHumansMaleMiddle AgedOpioid-Related DisordersPatient Acceptance of Health CareQualitative ResearchSocial StigmaYoung AdultEmotional distressOpioid addiction treatmentOpioid use disorderQualitative researchStigmaTreatment barriers

Identifiers

PMID28017184
PMCPMC5193128
OpenAlexW2553928236

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.